Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Stockholders' Deficit (Tables)

v3.7.0.1
Note 7 - Stockholders' Deficit (Tables)
9 Months Ended
Mar. 31, 2017
Notes Tables  
Schedule of Stock by Class [Table Text Block]
   
Value of
Common Stock
   
Shares of
Common Stock
 
                 
Shares issued in 2016 Private Placement as Loan Conversion
  $
400,000
     
10,000,000
 
Shares issued in 2016 Private Placement for Cash
   
1,075,000
     
26,875,000
 
Shares issued in 2016 Private Placement for Private Placement Subscription
   
-
     
2,500,000
 
Shares issued for Services Rendered
   
9,375
     
225,000
 
Shares issued in Warrant Exchange
   
10,089
     
1,633,950
 
Total
  $
1,494,464
     
41,233,950
 
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
 
 
Number of
Warrants
 
 
Weighted
Average
Exercise
Price Per
Warrant
 
 
Remaining
Contract
Term (#
years)
 
Warrants outstanding and exercisable at June 30, 2016
 
 
28,040,096
 
 
$
0.20
 
 
 
0.39
-
2.50
 
Warrants issued
 
 
-
 
 
$
-
 
 
 
-
 
 
Warrants exchanged
 
 
(
2,714,197
)
 
$
0.14
 
 
 
-
 
 
Warrants outstanding and exercisable at
March 31, 2017
 
 
25,325,900
 
 
$
0.
21
 
 
 
0.36
-
1.
70 
 
Share-based Compensation, Stock Options, Activity [Table Text Block]
 
 
Number of
Shares
 
 
Weighted
Average
Exercise Price
 
 
Weighted
Average
Remaining
Contract
Term (# years)
 
Outstanding at June 30, 2016
 
 
9,004,020
 
 
$
0.11
 
 
 
 
 
Granted
 
 
-
 
 
 
-
 
 
 
 
 
 
Exercised
 
 
-
 
 
 
-
 
 
 
 
 
 
Forfeited and cancelled
 
 
(
1,841,249
)
 
$
0.
16
 
 
 
 
 
Outstanding at
March 31, 2017
 
 
7,162,771
 
 
$
0.10
 
 
 
7.
34
 
Exercisable at
March 31, 2017
 
 
5,624,351
 
 
$
0.11
 
 
 
7.00
 
 
 
Number of
Shares
 
 
Weighted
Average
Exercise Price
 
 
Weighted
Average
Remaining
Contract
Term (# years)
 
Outstanding at June 30, 2015
 
 
6,101,357
 
 
$
0.15
 
 
 
 
 
Granted
 
 
4,385,000
 
 
 
0.05
 
 
 
 
 
Exercised
 
 
-
 
 
 
-
 
 
 
 
 
 
Forfeited and cancelled
 
 
(
1,239,837
)
 
 
0.1
3
 
 
 
 
 
Outstanding at
March 31, 2016
 
 
9,246,520
 
 
$
0.11
 
 
 
6.70
 
Exercisable at
March 31, 2016
 
 
6,467,999
 
 
$
0.1
3
 
 
 
5.55
 
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]
   
For the Three Months Ended
   
For the
Nine
Months Ended
 
   
March 31, 2017
   
March 31, 2016
   
March 31, 2017
   
March 31, 2016
 
Research and development
  $
3,000
    $
4,000
    $
10,000
    $
18,000
 
General and administration
   
7,000
     
17,000
     
20,000
     
81,000
 
Total stock-based compensation expense
  $
10,000
    $
21,000
    $
30,000
    $
99,000
 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Nine
months ended
March
31,
 
2017
   
2016
 
Expected volatility
   
100%
     
100%
 
Risk free interest rate
   
1.31%
     
1.31%
 
Forfeiture rate
   
23.0%
     
17%
 
Dividend yield
   
0%
     
0%
 
Expected term (years)
   
3
     
3